Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regional Health Properties | RHE | Sep 23, 2024 | 1.83 | +1.66 |
Regional Health Properties A Pref | RHE-A | Sep 23, 2024 | 0.51 | 0.00 |
Regional Management | RM | Sep 23, 2024 | 32.69 | +0.65 |
Regions Financial | RF | Sep 23, 2024 | 22.91 | -0.87 |
Regions Financial B Pref | RF-B | Sep 23, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Sep 23, 2024 | 25.11 | +0.52 |
Regions Financial E Pref | RF-E | Sep 23, 2024 | 19.63 | +0.67 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Sep 23, 2024 | 26.24 | 0.00 |
Regis | RGS | Sep 23, 2024 | 23.60 | -2.07 |
Regulus Therapeutics | RGLS | Sep 23, 2024 | 1.65 | -9.62 |
Reinsurance Group of America | RGA | Sep 23, 2024 | 220.26 | +0.29 |
REIT Index ETF Vanguard | VNQ | Sep 23, 2024 | 98.76 | +0.99 |
Reitar Logtech | RITR | Sep 23, 2024 | 4.19 | 0.00 |
Rekor Systems | REKR | Sep 23, 2024 | 1.20 | -0.83 |
Relay Therapeutics | RLAY | Sep 23, 2024 | 7.43 | -0.93 |
Reliance | RS | Sep 23, 2024 | 283.73 | +0.94 |
Reliance Global | RELI | Sep 23, 2024 | 2.39 | -5.91 |
Relmada Therapeutics | RLMD | Sep 23, 2024 | 3.50 | -0.28 |
RELX ADR | RELX | Sep 23, 2024 | 48.86 | +1.81 |
Remitly Global | RELY | Sep 23, 2024 | 14.00 | -0.92 |
Renaissance Ipo ETF | IPO | Sep 23, 2024 | 43.10 | +0.42 |
RenaissanceRe | RNR | Sep 23, 2024 | 264.55 | +0.33 |
RenaissanceRe G Pref | RNR-G | Sep 23, 2024 | 18.80 | 0.00 |
RenaissanceRe Holding F Pref | RNR-F | Sep 23, 2024 | 24.90 | -0.08 |
Renalytix ADR | RNLX | Sep 23, 2024 | 0.26 | -7.79 |
Renasant | RNST | Sep 23, 2024 | 33.16 | -0.72 |
Reneo Pharmaceuticals | RPHM | Sep 23, 2024 | 1.38 | -8.00 |
ReNew Energy Global A Shares | RNW | Sep 23, 2024 | 6.58 | +0.30 |
Renn Fund | RCG | Sep 23, 2024 | 2.04 | -0.97 |
Renovaro Biosciences | RENB | Sep 23, 2024 | 0.51 | -2.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.